News

Meituan (MPNGF) Q2 2025 Earnings Call Transcript

1 Mins read

Meituan (OTCPK:MPNGF) Q2 2025 Earnings Conference Call August 27, 2025 7:00 AM ET

Company Participants

Shaohui Chen – CFO & Senior VP
Sijia Xu – VP, Head of Capital Markets & Joint Company Secretary
Xing Wang – Co-Founder, Chairman & CEO

Conference Call Participants

Alicia Yap – Citigroup Inc., Research Division
Charlene Liu – HSBC Global Investment Research
Gary Yu – Morgan Stanley, Research Division
Kenneth Fong – UBS Investment Bank, Research Division
Ronald Keung – Goldman Sachs Group, Inc., Research Division
Thomas Chong – Jefferies LLC, Research Division
Ya Jiang – Citic Securities Co., Ltd., Research Division

Operator

Thank you for standing by, and welcome to the Meituan Second Quarter 2025 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to Scarlett Xu, VP and Head of Capital Markets. Please go ahead.

Sijia Xu

Thank you, operator. Good evening, and good morning, everyone. Welcome to our second quarter of 2025 earnings conference call. Joining us today are Mr. Xing Wang, Chairman and CEO and Mr. Shaohui Chen, Senior Vice President and CFO of Meituan.

For today’s call, management will first provide a review of our second quarter of 2025 results and then conduct a Q&A session. Before we start, we would like to remind you that our presentation contains forward-looking statements, which include a number of risks and uncertainties and may differ from actual results in the future. This presentation also contains unaudited non-IFRS accounting standard financial measures that should be considered in addition to and not as a substitute for measures of the company’s financial performance prepared in accordance with IFRS accounting standards. For a detailed discussion of risk factors and non-IFRS accounting standard measures, please refer to disclosure documents in the IR section of our website.

Now I will turn the call

Read the full article here

Related posts
News

Halozyme Therapeutics, Inc. (HALO) Discusses to Acquire ElektrofiConferenceCallTranscript

1 Mins read
Follow Play Earnings CallPlay Earnings Call Halozyme Therapeutics, Inc. (NASDAQ:HALO) Halozyme to Acquire Elektrofi Conference Call October 1, 2025 8:30 AM EDT…
News

Australian Foundation Investment Co (AFOVF) Shareholder/Analyst Call Transcript

1 Mins read
Company Participants Craig DrummondRobert Freeman – MD, CEO & DirectorDavid PeeverMatthew Rowe – Company SecretaryAndrew J. Porter – CFO & Company SecretaryGeoffrey…
News

Unilever: Strong Brands But Fragile Financials – Why I’m Bearish (NYSE:UL)

1 Mins read
This article was written by Follow I am a UK-based equity enthusiast and private investor with a professional background in finance. With…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *